FDA Inspection 1027562 - Halo Pharmaceutical, Inc. d/b/a Cambrex Whippany - August 24, 2017

View on Dashboard

Discuss this record with AI

ChatGPT

Claude

Perplexity

Grok

Copilot

Document or profile

One record shows the event. A profile shows the pattern.

Buy this document for the source file and details behind this single event.

Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.

Explore Halo Pharmaceutical, Inc. d/b/a Cambrex Whippany

Record Details

This FDA Inspection record concerns Halo Pharmaceutical, Inc. d/b/a Cambrex Whippany, with an inspection on August 24, 2017, issued by the Center for Drug Evaluation and Research, covering drugs.

Company: Halo Pharmaceutical, Inc. d/b/a Cambrex Whippany
Inspection Date: August 24, 2017
Product Type: Drugs
Office: Center for Drug Evaluation and Research

Open in Dashboard

ID · 1e78476d-5351-47de-8c53-bd1f0aae370e